The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

Moderna Inc. has agreed to do a placebo-controlled trial of its new COVID vaccine that was recently approved by U.S.

Rep. Marjorie Taylor Greene is sounding the alarm about a provision in the One Big Beautiful Bill Act that would restrict states from regulating artificial intelligence for a decade.

The findings underscore the need for continued surveillance to monitor the long-term dynamics of SARS-CoV-2 in deer and the ...

In its latest zoonotic flu update, the World Health Organization (WHO) said Bangladesh has notified it of two new human H5N1 ...

With U.S. recommendations for COVID-19 vaccines in flux, a leading member of the CDC's COVID vaccine advisory group is ...

Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Nearly 40 percent of long COVID patients suffer from the disorienting condition. Destroyed connections between brain cells may be to blame. A colored scanning electron micrograph of microglial ...